London: Britain’s medicines regulator on Wednesday approved the use of the Pfizer and BioNTech Covid-19 vaccine for children aged 5 to 11 years. The decision came after watchdog found the shot was safe and effective.
The country’s vaccines committee advised that children in the age group who were in a clinical risk group should be offered the shot.
The children will receive two 10-microgram doses of the Pfizer-BioNTech vaccine – a third of the adult dose – with an interval of eight weeks between the first and second doses, the Joint Committee on Vaccination and Immunisation said.
